Rationale for a New Outpatient Drug Therapy Algorithm in COVID-19 Patients Based on the Principle of «Multi-hit» Approach
- 25 June 2021
- journal article
- Published by Publishing House OKI in Antibiotics and Chemotherapy
- Vol. 66 (3-4), 49-61
- https://doi.org/10.37489/0235-2990-2021-66-3-4-49-61
Abstract
The aim of the work was to justify the algorithm of outpatient drug therapy in patients with COVID-19, based on the principle of «Multi-hit» Approach. The algorithm is based on the published results of clinical studies and observations, authors’ own practical experience in the use and management of more than 4 thousand patients diagnosed with COVID-19 of varying severity during the 2020 pandemic. The article substantiates a complex algorithm for the treatment of outpatients with COVID-19, which includes etiotropic, pathogenetic, and symptomatic components of therapy with different mechanisms of action. The described approach is the 1st stage (outpatient) of a complex algorithm for managing patients with COVID-19. It has been successfully implemented in the system of outpatient care for patients with novel coronavirus infections in several leading medical institutions in Russia. The authors believe that the developed algorithm for providing outpatient drug therapy for COVID-19, based on the principle of multiple exposure, may be useful in real clinical practice of managing patients with coronavirus infection.Keywords
This publication has 43 references indexed in Scilit:
- Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and SepsisAntimicrobial Agents and Chemotherapy, 2016
- Possible Protective Effect of Diacerein on Doxorubicin-Induced Nephrotoxicity in RatsJournal of Toxicology, 2016
- Mitochondrion-Permeable Antioxidants to Treat ROS-Burst-Mediated Acute DiseasesOxidative Medicine and Cellular Longevity, 2015
- Clarithromycin and dexamethasone show similar anti-inflammatory effects on distinct phenotypic chronic rhinosinusitis: an explant model studyBMC Immunology, 2015
- Anti-inflammatory effects of astaxanthin in the human gingival keratinocyte line NDUSD-1Journal of Clinical Biochemistry and Nutrition, 2015
- Low-Dose Clarithromycin Therapy Modulates Th17 Response In Non-Cystic Fibrosis Bronchiectasis PatientsLung, 2014
- Antiviral Properties, Metabolism, and Pharmacokinetics of a Novel Azolo-1,2,4-Triazine-Derived Inhibitor of Influenza A and B Virus ReplicationAntimicrobial Agents and Chemotherapy, 2010
- Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humansNutrition & Metabolism, 2010
- Clarithromycin Inhibits Type A Seasonal Influenza Virus Infection in Human Airway Epithelial CellsThe Journal of pharmacology and experimental therapeutics, 2009
- Astaxanthin suppresses scavenger receptor expression and matrix metalloproteinase activity in macrophagesEuropean Journal of Nutrition, 2009